OQROGet OQRO Pro
Insider trade

Rhythm Pharmaceuticals (RYTM)Officer sold ~$68K

Jennifer Kayden Lee, Officer at Rhythm Pharmaceuticals, sold ~$68K of Rhythm Pharmaceuticals shares.

~$68K
Approx. value · 1,205 sh @ $56.39
3,598
Holds after · shares reported
Traded
Feb 12, 2025
Filed
Feb 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 4, 2025Insider · 5 peopleInsiders: 5 sales (~$570K)
  2. Feb 5, 2025Insider · 1 personInsiders: 3 sales (~$186K)
  3. Feb 10, 2025Insider · 1 personInsiders: 2 sales (~$247K)
  4. Feb 11, 2025Insider · 4 peopleInsiders: 8 sales (~$220K)
  5. Feb 12, 2025 · this disclosureInsiderOfficer sold ~$68K of RYTM shares in the open market

What came next

  1. Feb 12, 2025Insider · 3 peopleInsiders: 6 sales (~$103K)
  2. Feb 13, 2025InsiderOfficer sold ~$70K of RYTM shares in the open market
  3. Feb 19, 2025Insider · 6 peopleInsiders: 6 sales (~$972K)
  4. Mar 14, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
  5. Mar 21, 2025InsiderOfficer sold ~$19K of RYTM shares in the open market
  6. Apr 8, 2025Insider · 2 peopleInsiders: 6 sales (~$2.3M)
  7. Apr 29, 2025Insider · 2 peopleInsiders: 2 sales (~$897K)
  8. May 30, 2025Insider · 1 personInsiders: 2 sales (~$1.4M)
  9. Jun 3, 2025Insider · 2 peopleInsiders: 4 sales (~$7.1M)
  10. Jun 6, 2025InsiderOfficer sold ~$478K of RYTM shares in the open market
  11. Jun 10, 2025InsiderOfficer sold ~$139K of RYTM shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rhythm Pharmaceuticals

For Rhythm Pharmaceuticals, OQRO holds 9 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RYTM page.

Other recent filings by Jennifer Kayden Lee, EVP, Head of North America

The full history of Jennifer Kayden Lee, EVP, Head of North America is on the profile page.

How this filing works

Other disclosures at Rhythm Pharmaceuticals

Everything OQRO holds on this company is on its RYTM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data